Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
出版年份 2021 全文链接
标题
Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
作者
关键词
Pancreatic ductal adenocarcinoma, Pancreatic cancer, Immunotherapy, Chemotherapy, Immunotherapeutic agents, Targeted immunotherapy
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 95, Issue -, Pages 107508
出版商
Elsevier BV
发表日期
2021-03-14
DOI
10.1016/j.intimp.2021.107508
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Larotrectinib: First Global Approval
- (2019) Lesley J. Scott DRUGS
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
- (2019) Ping Fan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma
- (2019) Alex B. Blair et al. JOURNAL OF CLINICAL INVESTIGATION
- ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
- (2019) Yan Jiao et al. OncoTargets and Therapy
- Current Status of Immunotherapies for Treating Pancreatic Cancer
- (2019) Annie A. Wu et al. Current Oncology Reports
- Neo-adjuvant therapy for pancreatic cancer: hope for the future
- (2019) Erkut Borazanci et al. Expert Review of Gastroenterology & Hepatology
- CD11b agonism overcomes PDAC immunotherapy resistance
- (2019) Iain Dickson Nature Reviews Gastroenterology & Hepatology
- Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies
- (2019) Roheena Z. Panni et al. Science Translational Medicine
- Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
- (2019) Tianjiao Li et al. Cancer Medicine
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression
- (2019) Julian Burks et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
- (2019) Akhil Chawla et al. Frontiers in Oncology
- Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma
- (2019) Yukihiko Hiroshima et al. CANCER LETTERS
- Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
- (2019) Anouk E.J. Latenstein et al. EUROPEAN JOURNAL OF CANCER
- Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice
- (2018) Concetta Panebianco et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular targeted therapy: treating cancer with specificity
- (2018) Yeuan Ting Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
- (2018) Shuji Isaji et al. PANCREATOLOGY
- Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
- (2018) Marc Hilmi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies
- (2018) Stephane Thibodeau et al. Journal of Clinical Medicine
- iRGD-guided tumor-penetrating nanocomplexes for therapeutic siRNA delivery to pancreatic cancer
- (2018) Justin H. Lo et al. MOLECULAR CANCER THERAPEUTICS
- Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
- (2018) MINELA ASLAN et al. ANTICANCER RESEARCH
- Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
- (2018) Sreenivasa Chandana et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
- (2018) Muhammad Ahsan Javed et al. PANCREATOLOGY
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
- (2017) Aleksandra Adamska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts.
- (2017) Zev A. Wainberg et al. JOURNAL OF CLINICAL ONCOLOGY
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma
- (2017) Aatur D. Singhi et al. Journal of the National Comprehensive Cancer Network
- Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
- (2017) Gary Middleton et al. LANCET ONCOLOGY
- Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
- (2017) Claire Vennin et al. Science Translational Medicine
- A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
- (2017) Gary A. Clawson et al. Nucleic Acid Therapeutics
- Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis
- (2017) KofiW Oppong et al. Endoscopic Ultrasound
- Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
- (2017) William K. Decker et al. Frontiers in Immunology
- P-286Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 study
- (2016) Picozzi Vincent et al. ANNALS OF ONCOLOGY
- Matrix control of pancreatic cancer: New insights into fibronectin signaling
- (2016) Mary Topalovski et al. CANCER LETTERS
- Modifiable and non-modifiable risk factors for pancreatic cancer: A review
- (2016) Shallu Midha et al. CANCER LETTERS
- Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer
- (2016) S. R. Hingorani et al. CLINICAL CANCER RESEARCH
- Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
- (2016) Mary Linton B. Peters et al. CLINICAL THERAPEUTICS
- Pancreatic Cancer
- (2016) Cinthya S. Yabar et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
- (2016) Yaqing Zhang et al. GUT
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
- (2016) Mark O'Hara et al. Immunotherapy
- Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells
- (2016) Vanna Sanna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer
- (2016) Mikio Kajihara WORLD JOURNAL OF GASTROENTEROLOGY
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer
- (2016) Sophie Dobiasch et al. JOURNAL OF NANOBIOTECHNOLOGY
- Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
- (2016) Marwan Ghosn et al. World Journal of Gastrointestinal Oncology
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
- (2015) Shuhei Mayanagi et al. CANCER SCIENCE
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- Antigen-loaded Dendritic Cell Migration: MR Imaging in a Pancreatic Carcinoma Model
- (2015) Zhuoli Zhang et al. RADIOLOGY
- Perspectives in the treatment of pancreatic adenocarcinoma
- (2015) Angel Cid-Arregui WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
- (2015) Shintaro Tsukinaga WORLD JOURNAL OF GASTROENTEROLOGY
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
- (2015) E. Gabriela Chiorean et al. Drug Design Development and Therapy
- Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer
- (2015) Hong Hua Yan et al. Oncotarget
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
- (2014) M. Aglietta et al. ANNALS OF ONCOLOGY
- Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
- (2014) Masanori Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
- (2014) Christian Bauer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
- (2014) S. Koido et al. CLINICAL CANCER RESEARCH
- Brief overview of selected approaches in targeting pancreatic adenocarcinoma
- (2014) Wesley R Samore et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Listeria Vaccine and Depletion of T-Regulatory Cells Activate Immunity Against Early Stage Pancreatic Intraepithelial Neoplasms and Prolong Survival of Mice
- (2014) Bridget P. Keenan et al. GASTROENTEROLOGY
- Antitumor effects of baculovirus-infected dendritic cells against human pancreatic carcinoma
- (2014) A Fujihira et al. GENE THERAPY
- A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
- (2014) Daniel Abate-Daga et al. HUMAN GENE THERAPY
- Expression of a Soluble TGF- Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy
- (2014) M. Zhang et al. JOURNAL OF IMMUNOLOGY
- Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
- (2014) Irene Esposito WORLD JOURNAL OF GASTROENTEROLOGY
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
- (2013) H Zhang et al. BRITISH JOURNAL OF CANCER
- Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
- (2013) E R Camp et al. CANCER GENE THERAPY
- Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
- (2013) Marijo Bilusic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD40 immunotherapy for pancreatic cancer
- (2013) Robert H. Vonderheide et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
- (2013) Tomar Ghansah et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
- (2013) Alexandr V. Bazhin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production
- (2013) Shigeo Koido et al. PLoS One
- Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
- (2013) Xiao-Bo Cheng et al. PLoS One
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Demographics and Epidemiology of Pancreatic Cancer
- (2012) Theresa Pluth Yeo et al. CANCER JOURNAL
- Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice
- (2012) Amit Maliar et al. GASTROENTEROLOGY
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer
- (2012) Andrew D. Gilliam et al. PANCREAS
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
- (2011) Else M. Inderberg Suso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma
- (2011) D. Z. Chang et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
- (2011) Yukino Kimura et al. PANCREAS
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Engineered Tcells for pancreatic cancer treatment
- (2011) Usha L. Katari et al. HPB
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine
- (2010) Ghassan K. Abou-Alfa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
- (2010) M. J. Strouch et al. CLINICAL CANCER RESEARCH
- Plectin-1 as a Novel Biomarker for Pancreatic Cancer
- (2010) D. Bausch et al. CLINICAL CANCER RESEARCH
- Epidemiology of Pancreatic Cancer: An Update
- (2010) Patrick Maisonneuve et al. DIGESTIVE DISEASES
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- The epidemiology of pancreatic cancer
- (2010) Gábor Lakatos et al. ORVOSI HETILAP
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
- (2009) Young Choon Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Epidemiology of pancreatic cancer: an overview
- (2009) Sara Raimondi et al. Nature Reviews Gastroenterology & Hepatology
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic Cancer
- (2008) Oriol Roda et al. GASTROENTEROLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation